{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:59:29Z","timestamp":1771826369705,"version":"3.50.1"},"reference-count":31,"publisher":"Jaypee Brothers Medical Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.59556\/japi.74.1299","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:03:51Z","timestamp":1771823031000},"page":"36-39","source":"Crossref","is-referenced-by-count":0,"title":["Early Initiation and Dose Optimization of Mineralocorticoid Receptor Antagonists in Heart Failure"],"prefix":"10.59556","volume":"74","author":[{"given":"Sunip","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeeve","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetan","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghunandan","family":"BK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna Prasad","family":"Anne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok","family":"Veer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhijeet","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvind","family":"Raghuvanshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Kedarnathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Febin","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarnath","family":"Sugumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthilnathan","family":"Mohanasundaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2914","reference":[{"issue":"(3):","key":"key20260223050349_B1","first-page":"196\u2013","article-title":"Foundation four therapy in heart failure: a real-world experience from a cardiac clinic in India.","volume":"5","author":"Pitchai","year":"2023;","journal-title":"Int J Dent Med Sci Res"},{"issue":"(1):","key":"key20260223050349_B2","first-page":"4\u2013","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.","volume":"24","author":"McDonagh","year":"2022;","journal-title":"Eur J Heart Fail"},{"issue":"(18):","key":"key20260223050349_B3","first-page":"e895\u2013","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"145","author":"Heidenreich","year":"2022;","journal-title":"Circulation"},{"issue":"(9):","key":"key20260223050349_B4","doi-asserted-by":"crossref","first-page":"875\u2013","DOI":"10.1161\/CIRCULATIONAHA.120.052926","article-title":"How should we sequence the treatments for heart failure and a reduced ejection fraction? A redefinition of evidence-based medicine.","volume":"143","author":"McMurray","year":"2021;","journal-title":"Circulation"},{"issue":"(19):","key":"key20260223050349_B5","doi-asserted-by":"crossref","first-page":"4325.","DOI":"10.3390\/jcm10194325","article-title":"Looking for a tailored therapy for heart failure: are we capable of treating the patient instead of the disease?","volume":"10","author":"Fucili","year":"2021;","journal-title":"J Clin Med"},{"issue":"(15):","key":"key20260223050349_B6","doi-asserted-by":"crossref","first-page":"1444\u2013","DOI":"10.1016\/j.jacc.2023.12.024","article-title":"2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure with Reduced Ejection Fraction.","volume":"83","author":"Maddox","year":"2024;","journal-title":"J Am Coll Cardiol"},{"issue":"(5):","key":"key20260223050349_B7","doi-asserted-by":"crossref","first-page":"504\u2013","DOI":"10.1016\/j.jacbts.2021.10.018","article-title":"Optimizing foundational therapies in patients with HFrEF: how do we translate these findings into clinical care?","volume":"7","author":"Sharma","year":"2022;","journal-title":"JACC Basic Transl Sci"},{"issue":"(2):","key":"key20260223050349_B8","doi-asserted-by":"crossref","first-page":"73\u2013","DOI":"10.1016\/j.jchf.2021.09.004","article-title":"A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction.","volume":"10","author":"Tromp","year":"2022;","journal-title":"JACC Heart Fail"},{"issue":"(2):","key":"key20260223050349_B9","doi-asserted-by":"crossref","first-page":"100296.","DOI":"10.1016\/j.clinme.2025.100296","article-title":"Early and rapid initiation of quadruple therapy for heart failure with reduced ejection fraction: a real-world experience.","volume":"25","author":"Sze","year":"2025;","journal-title":"Clin Med"},{"issue":"(1):","key":"key20260223050349_B10","doi-asserted-by":"crossref","first-page":"550\u2013","DOI":"10.1002\/ehf2.14604","article-title":"Guideline implementation, drug sequencing, and quality of care in heart failure: design and rationale of TITRATE-HF.","volume":"11","author":"Clephas","year":"2024;","journal-title":"ESC Heart Fail"},{"issue":"(7):","key":"key20260223050349_B11","doi-asserted-by":"crossref","first-page":"1549\u2013","DOI":"10.1002\/ejhf.3267","article-title":"Contemporary guideline-directed medical therapy in de novo, chronic, and worsening heart failure patients: first data from the TITRATE-HF study.","volume":"26","author":"Malgie","year":"2024;","journal-title":"Eur J Heart Fail"},{"issue":"(11):","key":"key20260223050349_B12","doi-asserted-by":"crossref","first-page":"1092\u2013","DOI":"10.1016\/j.jacc.2023.06.022","article-title":"Initiating mineralocorticoid antagonists for longstanding heart failure with reduced ejection fraction.","volume":"82","author":"Sauer","year":"2023;","journal-title":"JACC"},{"issue":"(10):","key":"key20260223050349_B13","doi-asserted-by":"crossref","first-page":"709\u2013","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999;","journal-title":"N Engl J Med"},{"issue":"(14):","key":"key20260223050349_B14","doi-asserted-by":"crossref","first-page":"1309\u2013","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003;","journal-title":"N Engl J Med"},{"issue":"(1):","key":"key20260223050349_B15","doi-asserted-by":"crossref","first-page":"11\u2013","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms.","volume":"364","author":"Zannad","year":"2011;","journal-title":"N Engl J Med"},{"issue":"(15):","key":"key20260223050349_B16","doi-asserted-by":"crossref","first-page":"1383\u2013","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction.","volume":"370","author":"Pitt","year":"2014;","journal-title":"N Engl J Med"},{"issue":"(16):","key":"key20260223050349_B17","doi-asserted-by":"crossref","first-page":"1475\u2013","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction.","volume":"391","author":"Solomon","year":"2024;","journal-title":"N Engl J Med"},{"issue":"(1):","key":"key20260223050349_B18","doi-asserted-by":"crossref","first-page":"1\u2013","DOI":"10.1016\/j.jchf.2022.08.009","article-title":"Heart Failure Drug Treatment-Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF).","volume":"11","author":"Savarese","year":"2023;","journal-title":"JACC Heart Fail"},{"issue":"(10):","key":"key20260223050349_B19","first-page":"e009295.","article-title":"Timing of statistical benefit of mineralocorticoid receptor antagonists among patients with heart failure and post-myocardial infarction.","volume":"15","author":"Bedrouni","year":"2022;","journal-title":"Circ Heart Fail"},{"issue":"(9):","key":"key20260223050349_B20","doi-asserted-by":"crossref","first-page":"1584\u2013","DOI":"10.1002\/ejhf.2975","article-title":"Mineralocorticoid receptor antagonist initiation during admission is associated with improved outcomes irrespective of ejection fraction in patients with acute heart failure.","volume":"25","author":"Beldhuis","year":"2023;","journal-title":"Eur J Heart Fail"},{"issue":"(10367):","key":"key20260223050349_B21","doi-asserted-by":"crossref","first-page":"1938\u2013","DOI":"10.1016\/S0140-6736(22)02076-1","article-title":"Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial.","volume":"400","author":"Mebazaa","year":"2022;","journal-title":"Lancet"},{"issue":"(1):","key":"key20260223050349_B22","doi-asserted-by":"crossref","first-page":"119\u2013","DOI":"10.1177\/1470320313482603","article-title":"Importance of the time of initiation of mineralocorticoid receptor antagonists on risk of mortality in patients with heart failure.","volume":"16","author":"Rossi","year":"2015;","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"(34):","key":"key20260223050349_B23","doi-asserted-by":"crossref","first-page":"2310\u2013","DOI":"10.1093\/eurheartj\/ehv273","article-title":"Clinical benefits of eplerenone in patients with systolic heart failure and mild symptoms when initiated shortly after hospital discharge: analysis from the EMPHASIS-HF trial.","volume":"36","author":"Girerd","year":"2015;","journal-title":"Eur Heart J"},{"issue":"(11):","key":"key20260223050349_B24","doi-asserted-by":"crossref","first-page":"1099\u2013","DOI":"10.1093\/eurjhf\/hfp136","article-title":"Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial.","volume":"11","author":"Adamopoulos","year":"2009;","journal-title":"Eur J Heart Fail"},{"issue":"(8):","key":"key20260223050349_B25","doi-asserted-by":"crossref","first-page":"1444\u2013","DOI":"10.1002\/ejhf.2952","article-title":"Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: a subgroups analysis from the EMPHASIS-HF trial.","volume":"25","author":"Monzo","year":"2023;","journal-title":"Eur J Heart Fail"},{"issue":"(9):","key":"key20260223050349_B26","first-page":"e45241.","article-title":"Impact of mineralocorticoid receptor antagonists in the treatment of heart failure: targeting the heart failure cascade.","volume":"15","author":"Jadhav","year":"2023;","journal-title":"Cureus"},{"issue":"(5):","key":"key20260223050349_B27","doi-asserted-by":"crossref","first-page":"595\u2013","DOI":"10.3904\/kjim.2023.223","article-title":"Optimization of guideline-directed medical treatment for heart failure patients with reduced ejection fraction.","volume":"38","author":"Bak","year":"2023;","journal-title":"Korean J Intern Med"},{"issue":"(8):","key":"key20260223050349_B28","first-page":"902\u2013","article-title":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES]).","volume":"78","author":"The RALES Investigators.","year":"1996;","journal-title":"Am J Cardiol"},{"issue":"(8):","key":"key20260223050349_B29","doi-asserted-by":"crossref","first-page":"781\u2013","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.","volume":"309","author":"Edelmann","year":"2013;","journal-title":"JAMA"},{"issue":"(2):","key":"key20260223050349_B30","doi-asserted-by":"crossref","first-page":"243\u2013","DOI":"10.1007\/s40119-024-00367-4","article-title":"Management of heart failure in a resource-limited setting: expert opinion from India.","volume":"13","author":"Jain","year":"2024;","journal-title":"Cardiol Ther"},{"issue":"(37):","key":"key20260223050349_B31","doi-asserted-by":"crossref","first-page":"3627\u2013","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"44","author":"McDonagh","year":"2023;","journal-title":"Eur Heart J"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:03:55Z","timestamp":1771823035000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-74-1-s1-36"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.59556\/japi.74.1299"],"URL":"https:\/\/doi.org\/10.59556\/japi.74.1299","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}